Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Finch Therapeutics Gr Q1 EPS $(1.33) Down From $(0.52) YoY, Sales $107.00K Down From $354.00K YoY

Author: Benzinga Newsdesk | May 10, 2023 07:21am
Finch Therapeutics Gr (NASDAQ:FNCH) reported quarterly losses of $(1.33) per share. This is a 155.77 percent decrease over losses of $(0.52) per share from the same period last year. The company reported $107.00 thousand in sales this quarter. This is a 69.77 percent decrease over sales of $354.00 thousand the same period last year.

Posted In: FNCH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist